Registry for transcatheter repair of tricuspid regurgitation

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This registry investigates the clinical and survival outcomes of patients undergoing transcatheter tricuspid valve repair or replacement. It aims to optimize patient selection for these procedures by collecting real-world data on treatment outcomes. The study focuses on patients with tricuspid regurgitation, a condition that significantly impacts heart health and quality of life. By analyzing the effectiveness of various transcatheter devices, the registry seeks to improve treatment strategies for this high-risk patient population.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Patients treated with one of the following transcatheter devices for TV repair or replacement: PASCAL, TriClip, TricValve, Evoque, LuX-Valve
* Age ≥ 18 years

Where it's running

• LMU Klinikum
  Munich, Bavaria, Germany Recruiting

Study contacts

• Study coordinator: Jörg Hausleiter, Prof. Dr.
• Email: Joerg.Hausleiter@med.uni-muenchen.de
• Phone: +49 89 4400 72360

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Longitudinal Assessment of Cardiac MRI Microstructure in Patients and Healthy People

  This study tests advanced, non-contrast and extended clinical cardiac MRI techniques to see how heart tissue features differ between people with heart disease and healthy individuals.

  Recruiting The Cleveland Clinic · Cleveland, Ohio · NCT07081711

• Assessing arterial stiffness and heart disease risk using a novel technology

  This study is testing a new, no-touch technology to measure how stiff your arteries are and see if it can help figure out your risk for heart disease.

  Recruiting at 3 sites HJN Sverige AB/Neko Health · Stockholm and 2 other locations · NCT06984211

• Characterizing patients and outcomes in severe tricuspid regurgitation

  This study looks at people with severe tricuspid regurgitation to see who can get a new heart valve treatment and how well it works for them.

  Recruiting Medical University of Warsaw · Warsaw, Masovian Voivodeship · NCT06838611

• Using Apple Watch data to predict heart failure outcomes

  This study is testing if data from Apple Watches can help predict heart failure problems and the chances of needing to go back to the hospital for patients with heart failure.

  Recruiting University Medical Center Goettingen · Goettigen, Lower Saxony · NCT06819618

• AI-based assessment of heart function using ECG wearable monitors

  This study tests if a new AI tool using a wearable heart monitor can accurately check heart function in people with heart failure compared to traditional heart scans.

  Recruiting at 8 sites Peerbridge Health, Inc · Orange, California and 7 other locations · NCT06699056

• Comparing MitraClip and PASCAL for treating mitral regurgitation

  This study is testing two devices, MitraClip and PASCAL, to see which one works better for treating mitral regurgitation in patients who need this heart procedure.

  Recruiting LMU Klinikum · Munich, Bavaria · NCT06634121

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.